Capital Impact Advisors, LLC Shockwave Medical, Inc. Transaction History

Capital Impact Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$191.17 - $325.63 $524,570 - $893,528	2,744 New	2,744 $893,000
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $431,155 - $585,080	-1,933 Reduced 40.0%	2,899 $827,000
Q1 2023 May 23, 2023	BUY	$175.41 - $217.92 $26,486 - $32,905	151 Added 3.23%	4,832 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $69,284 - $100,621	339 Added 7.81%	4,681 $962,000
Q3 2022 Nov 21, 2022	SELL	$195.21 - $310.53 $59,929 - $95,332	-307 Reduced 6.6%	4,342 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$115.91 - $214.48 $92,264 - $170,726	-796 Reduced 14.62%	4,649 $889,000
Q1 2022 May 16, 2022	BUY	$127.96 - $207.36 $696,742 - $1.13 Million	5,445 New	5,445 $1.13 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.